Vebeglogene Autotemcel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vebeglogene Autotemcel, covering 2025-11-25 to 2025-11-25. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion Dependent Beta-Thalassemia [Phase 1, Phase 2]